Skip to main content
HCPCS J1740 · Level II · Part B drug

J1740: ibandronate sodium, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J1740

Billing unit
1 MG
Ibandronate sodium injection
ASP payment limit
$43.68
October 2026; -3.3% vs July 2026
Practitioner MUE
3
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
2
9 states

TL;DR

HCPCS J1740 is the Level II code for Injection, ibandronate sodium, 1 mg, billed per 1 MG. The Medicare Part B ASP payment limit for October 2026 is $43.68 per billing unit, down 3.3% from July 2026. The practitioner MUE allows up to 3 units per date of service (MAI 3), so a full 3-unit day is $131.04 at the current limit. Under OPPS it carries status indicator N. With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. The ASP crosswalk maps 3 NDCs to it, sold as Ibandronate Sodium by Sagent Pharmaceuticals, Eugia US LLC, Apotex Corp. 2 Medicare coverage articles list the code across 9 states, including A52421.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J1740 at $43.68 per 1 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $45.154 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J1740
QuarterPayment limitPerCoinsurance
October 2026$43.681 MG20%
July 2026$45.1541 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 3 NDCs from 3 labelers to J1740. Report the NDC in the claim's drug segment and bill the number of J1740 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.

NDCs that crosswalk to J1740
NDCDrug nameLabelerPackage sizeBilling units / package
25021-0827-61Ibandronate SodiumSagent Pharmaceuticals3 × 13
55150-0191-83Ibandronate SodiumEugia US LLC3 × 13
60505-6097-00Ibandronate SodiumApotex Corp3 × 13

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J1740. For practitioners the limit is 3 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J1740 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services33 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital33 Date of Service Edit: ClinicalPrescribing Information
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J1740 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J1740 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J1740 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J1740 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

2 current Medicare Administrative Contractor articles list J1740 in their HCPCS tables, covering 9 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J1740
ArticleTitleContractor(s)StatesRelated LCD
A52421Billing and Coding: Ibandronate SodiumWellpoint FederalCT IL MN NY WIL33394
A56907Billing and Coding: Bisphosphonate Drug TherapyWisconsin Physicians Service Insurance CorporationIA KS MO NEL34648, L39721

Diagnoses Medicare contractors cover for J1740

2 billing and coding articles attach a covered diagnosis list to J1740: 294 distinct ICD-10-CM codes in all. The 15 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 15 covered ICD-10-CM codes for J1740
ICD-10-CMDescription (FY2027)Articles covering
C79.51Secondary malignant neoplasm of bone2 of 2
E83.52Hypercalcemia2 of 2
M80.011AAge-related osteoporosis with current pathological fracture, right shoulder, initial encounter for fracture2 of 2
M80.012AAge-related osteoporosis with current pathological fracture, left shoulder, initial encounter for fracture2 of 2
M80.021AAge-related osteoporosis with current pathological fracture, right humerus, initial encounter for fracture2 of 2
M80.022AAge-related osteoporosis with current pathological fracture, left humerus, initial encounter for fracture2 of 2
M80.031AAge-related osteoporosis with current pathological fracture, right forearm, initial encounter for fracture2 of 2
M80.032AAge-related osteoporosis with current pathological fracture, left forearm, initial encounter for fracture2 of 2
M80.041AAge-related osteoporosis with current pathological fracture, right hand, initial encounter for fracture2 of 2
M80.042AAge-related osteoporosis with current pathological fracture, left hand, initial encounter for fracture2 of 2
M80.051AAge-related osteoporosis with current pathological fracture, right femur, initial encounter for fracture2 of 2
M80.052AAge-related osteoporosis with current pathological fracture, left femur, initial encounter for fracture2 of 2
M80.061AAge-related osteoporosis with current pathological fracture, right lower leg, initial encounter for fracture2 of 2
M80.062AAge-related osteoporosis with current pathological fracture, left lower leg, initial encounter for fracture2 of 2
M80.071AAge-related osteoporosis with current pathological fracture, right ankle and foot, initial encounter for fracture2 of 2
279 more codes are in the full lists linked below.

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J1740 are counted here: a group whose instructions name J1740, together with any unnamed groups directly after it, read as continuations of those instructions. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to J1740, by article
ArticleContractorGroups that applyCovered codes for J1740Full list
A52421Wellpoint Federalone list for every code in the article254On LCD L33394
A56907Wisconsin Physicians Service Insurance Corporationgroup 3 applies to J174094On LCD L34648

Local coverage policies that list J1740

2 active Local Coverage Determinations list J1740 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J1740 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J1740 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J1740 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J1740

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J1740

What does HCPCS code J1740 describe?

J1740 is defined by CMS as "Injection, ibandronate sodium, 1 mg". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J1740 a CPT code?

No. J1740 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as ibandronate sodium; CPT codes are five-character codes maintained by the AMA. On a Part B claim J1740 reports the drug itself in 1 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J1740 in October 2026?

The ASP-based payment limit is $43.68 per 1 MG, with 20% beneficiary coinsurance. The July 2026 limit was $45.154. Commercial payers use their own fee schedules.

How many units of J1740 can be billed per day?

The practitioner Medically Unlikely Edit is 3 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J1740?

The October 2026 ASP crosswalk lists 3 NDCs from 3 labelers: Ibandronate Sodium (Sagent Pharmaceuticals); Ibandronate Sodium (Eugia US LLC); Ibandronate Sodium (Apotex Corp). For example NDC 25021-0827-61 (package size 3) equals 3 billing units of J1740.

Does J1740 have NCCI bundling edits?

No active practitioner PTP pairs list J1740 as a column-1 or column-2 code in the v323r0 release.

Which Medicare coverage articles mention J1740?

2 current Billing and Coding Articles in the Medicare Coverage Database list J1740, covering 9 states: A52421 (Billing and Coding: Ibandronate Sodium); A56907 (Billing and Coding: Bisphosphonate Drug Therapy).

What diagnosis codes support J1740?

2 Medicare billing and coding articles list 294 covered ICD-10-CM codes for J1740 between them, for example C79.51 (Secondary malignant neoplasm of bone); E83.52 (Hypercalcemia); M80.011A (Age-related osteoporosis with current pathological fracture, right shoulder, initial encounter for fracture); M80.012A (Age-related osteoporosis with current pathological fracture, left shoulder, initial encounter for fracture); M80.021A (Age-related osteoporosis with current pathological fracture, right humerus, initial encounter for fracture). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.